• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强老年人免疫反应的疫苗策略。

Vaccine strategies to enhance immune responses in the aged.

机构信息

Trudeau Institute, 154 Algonquin Avenue, Saranac Lake, NY 12983, USA.

出版信息

Curr Opin Immunol. 2013 Aug;25(4):523-8. doi: 10.1016/j.coi.2013.05.014. Epub 2013 Jun 10.

DOI:10.1016/j.coi.2013.05.014
PMID:23764092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3775954/
Abstract

The elderly population is more susceptible to infections with higher risks of morbidity and mortality. This is caused by the accumulation of immune defects with aging. The best way to protect people against infections is vaccination. Unfortunately, the same immune defects that render the elderly susceptible to infectious diseases also prevent the development of protective immunity following immunization. A good example of this is the influenza vaccine that only protects between 40 and 60% of the vaccinees over 65 years. In the past decade, tremendous efforts have been put toward improving the influenza vaccine for the elderly. We therefore use this example to present various strategies employed to overcome these age-associated immune defects and hence make vaccines more efficacious for the aged.

摘要

老年人更容易受到感染,发病率和死亡率更高。这是由于随着年龄的增长,免疫缺陷的积累造成的。保护人们免受感染的最佳方法是接种疫苗。不幸的是,导致老年人易患传染病的相同免疫缺陷也阻止了免疫接种后保护性免疫的产生。流感疫苗就是一个很好的例子,它只能保护 65 岁以上的疫苗接种者 40%至 60%。在过去的十年中,人们为改善老年人的流感疫苗做出了巨大的努力。因此,我们以流感疫苗为例,介绍了克服这些与年龄相关的免疫缺陷的各种策略,从而使疫苗对老年人更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/086b/3775954/d70b4928278a/nihms496390f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/086b/3775954/d70b4928278a/nihms496390f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/086b/3775954/d70b4928278a/nihms496390f1.jpg

相似文献

1
Vaccine strategies to enhance immune responses in the aged.增强老年人免疫反应的疫苗策略。
Curr Opin Immunol. 2013 Aug;25(4):523-8. doi: 10.1016/j.coi.2013.05.014. Epub 2013 Jun 10.
2
Vaccine adjuvants: smart components to boost the immune system.疫苗佐剂:增强免疫系统的智能组件。
Arch Pharm Res. 2017 Nov;40(11):1238-1248. doi: 10.1007/s12272-017-0969-z. Epub 2017 Oct 13.
3
Vaccines for the elderly.老年人疫苗。
Clin Microbiol Infect. 2012 Oct;18 Suppl 5:100-8. doi: 10.1111/j.1469-0691.2012.03944.x. Epub 2012 Aug 6.
4
Immunosenescence and vaccine failure in the elderly: strategies for improving response.老年人的免疫衰老与疫苗接种失败:改善免疫反应的策略
Immunol Lett. 2014 Nov;162(1 Pt B):346-53. doi: 10.1016/j.imlet.2014.06.006. Epub 2014 Jun 21.
5
Novel vaccine development strategies for inducing mucosal immunity.诱导黏膜免疫的新型疫苗研发策略。
Expert Rev Vaccines. 2012 Mar;11(3):367-79. doi: 10.1586/erv.11.196.
6
Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.黏膜疫苗:黏膜佐剂与递送载体开发中的范式转变。
APMIS. 2015 Apr;123(4):275-88. doi: 10.1111/apm.12351. Epub 2015 Jan 29.
7
New insights in mucosal vaccine development.黏膜疫苗研发的新视角。
Vaccine. 2012 Jan 5;30(2):142-54. doi: 10.1016/j.vaccine.2011.11.003. Epub 2011 Nov 12.
8
Leptin-based adjuvants: an innovative approach to improve vaccine response.基于瘦素的佐剂:提高疫苗应答的创新方法。
Vaccine. 2013 Mar 25;31(13):1666-72. doi: 10.1016/j.vaccine.2013.01.032. Epub 2013 Jan 29.
9
Vaccine adjuvants: key tools for innovative vaccine design.疫苗佐剂:创新疫苗设计的关键工具。
Curr Top Med Chem. 2013;13(20):2562-80. doi: 10.2174/15680266113136660183.
10
Perspectives on vaccine development for the elderly.老年人疫苗开发的观点。
Curr Opin Immunol. 2013 Aug;25(4):529-34. doi: 10.1016/j.coi.2013.07.008. Epub 2013 Aug 31.

引用本文的文献

1
Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals.社论:感染和接种疫苗个体对严重急性呼吸综合征冠状病毒2的固有免疫反应
Front Immunol. 2023 Feb 8;14:1141405. doi: 10.3389/fimmu.2023.1141405. eCollection 2023.
2
Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.接种者的先天免疫反应决定了接种 ChAdOx1nCoV-19 后的早期中和抗体产生。
Front Immunol. 2022 Jan 25;13:807454. doi: 10.3389/fimmu.2022.807454. eCollection 2022.
3
Network Topology of Biological Aging and Geroscience-Guided Approaches to COVID-19.

本文引用的文献

1
Aging of the CD4 T Cell Compartment.CD4 T细胞区室的衰老
Open Longev Sci. 2012 Jan 1;6:83-91. doi: 10.2174/1876326X01206010083.
2
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.AS03 佐剂与无佐剂灭活三价流感疫苗在老年人中的季节性流感预防效果:一项 3 期随机试验。
Lancet Infect Dis. 2013 Jun;13(6):485-96. doi: 10.1016/S1473-3099(13)70046-X. Epub 2013 Mar 19.
3
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.
生物衰老的网络拓扑结构与以老年科学为导向的 COVID-19 应对方法
Front Aging. 2021 Jul;2. doi: 10.3389/fragi.2021.695218. Epub 2021 Jul 23.
4
New MoDC-Targeting TNF Fusion Proteins Enhance Cyclic Di-GMP Vaccine Adjuvanticity in Middle-Aged and Aged Mice.新型靶向树突状细胞的 TNF 融合蛋白增强了中老年小鼠环二鸟苷酸疫苗的佐剂活性。
Front Immunol. 2020 Aug 7;11:1674. doi: 10.3389/fimmu.2020.01674. eCollection 2020.
5
Study of the Immune Response in the Elderly: Is It Necessary to Develop a Vaccine against for the Aged?老年人免疫反应的研究:是否有必要研发针对老年人的疫苗?
J Aging Res. 2019 Aug 22;2019:9287121. doi: 10.1155/2019/9287121. eCollection 2019.
6
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.细菌蛋白 Toll 样受体激动剂:疫苗佐剂的新视角。
Front Immunol. 2019 May 29;10:1144. doi: 10.3389/fimmu.2019.01144. eCollection 2019.
7
Attrition of T Cell Zone Fibroblastic Reticular Cell Number and Function in Aged Spleens.老年脾脏中T细胞区成纤维网状细胞数量及功能的损耗
Immunohorizons. 2018 May;2(5):155-163. doi: 10.4049/immunohorizons.1700062. Epub 2018 Jul 23.
8
Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.佐剂流感 H1N1 疫苗增强了年轻和老年小鼠的免疫应答。
Front Immunol. 2018 Feb 19;9:295. doi: 10.3389/fimmu.2018.00295. eCollection 2018.
9
Interventions to restore appropriate immune function in the elderly.恢复老年人适当免疫功能的干预措施。
Immun Ageing. 2018 Jan 25;15:5. doi: 10.1186/s12979-017-0111-6. eCollection 2018.
10
Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination.流感疫苗接种后老年个体中与免疫衰老相关的转录组学和免疫学变化
Front Immunol. 2016 Nov 2;7:450. doi: 10.3389/fimmu.2016.00450. eCollection 2016.
一项II期随机临床试验,旨在证明低剂量MF59佐剂大流行前A/H5N1流感疫苗在成人和老年受试者中的非劣效性。
J Prev Med Hyg. 2012 Sep;53(3):136-42.
4
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.60岁以上患者皮内注射流感疫苗与病毒体流感疫苗的直接比较:免疫原性、交叉保护、安全性及耐受性评估
Hum Vaccin Immunother. 2013 Mar;9(3):591-8. doi: 10.4161/hv.23240. Epub 2013 Jan 7.
5
High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season.高剂量三价流感疫苗与老年人标准剂量疫苗的比较:2009-2010 年季节期间的安全性、免疫原性和相对疗效。
Vaccine. 2013 Jan 30;31(6):861-6. doi: 10.1016/j.vaccine.2012.12.013. Epub 2012 Dec 20.
6
Aging affects epidermal Langerhans cell development and function and alters their miRNA gene expression profile.衰老会影响表皮朗格汉斯细胞的发育和功能,并改变其微小RNA基因表达谱。
Aging (Albany NY). 2012 Nov;4(11):742-54. doi: 10.18632/aging.100501.
7
A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.一种用于老年人的 T 细胞诱导型流感疫苗:MVA-NP+M1 在 50 岁以上成年人中的安全性和免疫原性。
PLoS One. 2012;7(10):e48322. doi: 10.1371/journal.pone.0048322. Epub 2012 Oct 31.
8
Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.评估成人和老年受试者对一种含MF59佐剂的A/H5N1大流行前流感疫苗的抗原特异性和交叉反应性抗体反应。
Clin Vaccine Immunol. 2012 Dec;19(12):1943-8. doi: 10.1128/CVI.00373-12. Epub 2012 Oct 17.
9
Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections.对保守的流感核蛋白的免疫可降低对继发细菌性感染的易感性。
J Immunol. 2012 Nov 15;189(10):4921-9. doi: 10.4049/jimmunol.1201916. Epub 2012 Oct 1.
10
A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events.皮内与肌内接种流感疫苗的荟萃分析:免疫原性和不良事件。
Influenza Other Respir Viruses. 2013 Jul;7(4):584-603. doi: 10.1111/irv.12000. Epub 2012 Sep 13.